To view a copy of this licence, visit About this article Cite this article Jia, J., Liu, Y., Wang, D
Recent studies on long-acting GLP-1s in type 1 diabetes have shown promising results, including reductions in A1C levels and increased time within the target blood sugar range, without diabetic ketoacidosis or significant hypoglycemic episodes.It is well-established that elevated A1C levels can increase the risk of cardiovascular complications and kidney disease in individuals with T1D
Additionally, berberine and other patch ingredients can cause side effects such as: Upset stomach Diarrhea Constipation Excess gas The severity and duration of these side effects are uncertain, unlike GLP-1 injections, whose side effects are well-documented and tend to stabilize over time
For most people with fibromyalgia, the choice between Wegovy and Mounjaro will come down to factors that arent specific to fibromyalgia: tolerability, cost, availability, prescriber recommendation, and personal preference
This amplifies the many challenges associated with GLP-1s, like gastrointestinal side effects, nutrient inadequacies, muscle and bone loss, low long-term adherence, weight regain, and high costs
Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T (2018) Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats
